14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $141.16 $183.01 Friday, 3rd May 2024 GRTS stock ended at $0.96. This is 10.66% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 13.18% from a day low at $0.88 to a day high of $1.00.
90 days $141.16 $227.30
52 weeks $84.73 $227.30

Historical Gritstone Oncology Inc. prices

Date Open High Low Close Volume
May 03, 2024 $0.90 $1.00 $0.88 $0.96 4 181 125
May 02, 2024 $0.88 $0.90 $0.83 $0.87 1 932 348
May 01, 2024 $0.81 $0.91 $0.80 $0.87 2 665 872
Apr 30, 2024 $0.82 $0.82 $0.780 $0.80 1 210 078
Apr 29, 2024 $0.82 $0.84 $0.80 $0.81 1 038 303
Apr 26, 2024 $0.758 $0.84 $0.758 $0.81 1 100 052
Apr 25, 2024 $0.81 $0.81 $0.754 $0.765 1 043 664
Apr 24, 2024 $0.736 $0.82 $0.726 $0.81 1 870 645
Apr 23, 2024 $0.730 $0.782 $0.721 $0.739 2 406 457
Apr 22, 2024 $0.727 $0.760 $0.685 $0.746 3 334 166
Apr 19, 2024 $0.746 $0.775 $0.709 $0.737 1 518 568
Apr 18, 2024 $0.742 $0.768 $0.724 $0.744 2 083 573
Apr 17, 2024 $0.790 $0.795 $0.736 $0.745 3 055 013
Apr 16, 2024 $0.726 $0.84 $0.672 $0.772 4 482 522
Apr 15, 2024 $0.86 $0.87 $0.720 $0.739 5 619 794
Apr 12, 2024 $0.93 $0.93 $0.83 $0.84 4 218 766
Apr 11, 2024 $0.96 $0.96 $0.92 $0.92 2 323 860
Apr 10, 2024 $0.97 $0.98 $0.93 $0.95 3 767 180
Apr 09, 2024 $1.03 $1.05 $0.96 $0.98 2 476 749
Apr 08, 2024 $1.00 $1.05 $0.99 $1.01 3 589 387
Apr 05, 2024 $1.02 $1.06 $0.95 $0.97 7 233 066
Apr 04, 2024 $1.18 $1.18 $1.00 $1.04 9 494 934
Apr 03, 2024 $1.22 $1.23 $1.17 $1.19 4 711 821
Apr 02, 2024 $1.30 $1.36 $1.16 $1.20 24 923 454
Apr 01, 2024 $2.67 $2.67 $2.28 $2.35 4 397 947
Click to get the best stock tips daily for free!

About Gritstone Oncology Inc.

Gritstone Oncology. Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder and microsatellite stable, and colorectal cancers. The company is also developing SLATE, an off-the-she... GRTS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT